Anti-obesity medication: these are the surprising effects of taking Ozempic and Mounjaro - As weight loss jabs becomes ...

Adding an anti-obesity medication just one month after behavioral therapy begins—rather than waiting the currently ...

A clinical guidance from the American College of Cardiology Solution Set Oversight Committee states that pharmacotherapy may ...

Adding an anti-obesity medication just one month after behavioral therapy begins-rather than waiting the currently recommended six months-can more than double weight loss for patients who struggle ...

Anti-obesity medications are often used to help people who have tried and not been able to lose enough weight through exercise and dietary changes. Obesity is a widespread issue affecting over 40% ...

Data from 2019 to 2023 show 9.2% of adults with obesity reported cost-related medication adherence. June 24th 2025 Musculoskeletal Disorders in Postmenopausal Women Are Rising Worldwide ...

The best way to address employers' concerns is to improve employee utilization of weight loss benefits, according to Saunders ...

Eli Lillys Mounjaro KwikPen gains approval in India, targeting diabetes and obesity with its dual-action formula for weight ...

A new weight loss drug which appears to cause fat cells to create heat, literally burning it away, has been discovered by ...

Eli Lilly's once-weekly KwikPen format for Mounjaro has been approved in India, offering an easier delivery system for type 2 ...

Recent studies demonstrate this clearly. For example, in the SURMOUNT-4 trial involving tirzepatide (Zepbound), participants achieved an average weight loss of 20.9% after 36 weeks on the medication.